Since your trial period will likely be limited (often 1–2 weeks), do not try to learn every feature. Focus on the "Core Four" that make ArtiosCAD the industry standard:
The Artiosca Trial is expected to provide valuable insights into the cardiovascular effects of Artiosca in patients with established cardiovascular disease. If the trial demonstrates a significant reduction in MACE and other cardiovascular events, Artiosca may become a new treatment option for patients with cardiovascular disease. artioscad trial